Isolated perfused rat hearts. Hearts were isolated from mature male Wistar rats as described previously (24) (25) (26) 28) . Rats were anesthetized with 50 mg/kg pentobarbital sodium, a thoracotomy was performed, and the hearts were rapidly excised into ice-cold perfusion fluid. The aorta was immediately cannulated and hearts were perfused in a retrograde manner at a constant hydrostatic pressure of 100 mmHg with modified Krebs bicarbonate buffer containing (in mM) 120
adenosine; calcium; cardioplegia; free energy of adenosine 5Ј-triphosphate hydrolysis; phosphorus-31 nuclear magnetic resonance spectroscopy; rat hearts ELEVATED EXTRACELLULAR Mg 2ϩ ([Mg 2ϩ ] o ) is employed in cardioplegic solutions, where it improves myocardial recovery (29) . Mg 2ϩ treatment is used in a variety of cardiovascular disorders including myocardial infarction and arrhythmias (3, 44, 47) . Moreover, a number of cardiovascular disorders have been associated with low extracellular or cellular [Mg 2ϩ ] including hypertension, myocardial infarction, arrhythmias, and congestive heart failure (3, 44) . Given the variety of clinical uses of elevated Mg 2ϩ , and the implication of Mg 2ϩ imbalances in cardiovascular pathophysiologies, it is relevant to develop our understanding of the mechanisms of action of [Mg 2ϩ ] o . There remains some controversy regarding the functional effects of [Mg 2ϩ ] o in myocardial tissue, and few studies have examined the metabolic or energetic effects of [Mg 2ϩ ] o in mammalian heart.
In most studies [Mg 2ϩ ] o is shown to exert negative inotropic and chronotropic effects in cardiac tissue (8, 12, 17, 22, 31, 48, 49) , although there is paradoxical evidence for positive inotropic effects of moderate elevations in [Mg 2ϩ ] o (6, 32) . Additionally, there are conflicting data regarding underlying mechanisms of action of [Mg 2ϩ ] o . Some studies support extracellular mechanisms of action (e.g., inhibition of sarcolemmal Ca 2ϩ fluxes) (1, 32, 49) , whereas others support modification of intracellular processes [e.g., sarcoplasmic reticulum (SR) Ca 2ϩ handling] by associated elevations in intracellular Mg 2ϩ ([Mg 2ϩ ] i ) (6, 51) . Similarly, although it has been reported that a modest elevation in [Mg 2ϩ ] o improves myocardial energy state (6) , the underlying mechanisms are undefined. A Mg 2ϩ -dependent improvement of cytosolic free energy state could be particularly beneficial in settings of heart failure, ischemia, and cardioplegia.
Generally speaking, elevations in [Mg 2ϩ ] o may alter myocardial contractile function in two ways: 1) modulation of sarcolemmal Ca 2ϩ fluxes by external Mg 2ϩ , and/or 2) modification of myofibrillar and SR function by associated elevations in [Mg 2ϩ ] i . Similarly, elevations in [Mg 2ϩ ] o may alter cytosolic free energy state by inhibition of sarcolemmal Ca 2ϩ fluxes (reducing myocardial work and energy demand) and/or improvement of substrate and energy metabolism via elevations in [Mg 2ϩ ] i . An additional indirect mechanism involves stimulation of adenosine formation (38) with resultant activation of cardiovascular adenosine receptors.
In an attempt to resolve some of the many remaining issues regarding functional and metabolic effects of extracellular Mg 2ϩ in mammalian myocardium we have 1) characterized functional and metabolic effects of graded elevations in [Mg 2ϩ ] o in perfused rat heart; 2) compared response to elevated [Mg 2ϩ ] o with those to reduced extracellular Ca 2ϩ concentration ([Ca 2ϩ ] o ) or to Ca 2ϩ channel blockade; 3) examined the role of associated changes in [Mg 2ϩ ] i in metabolic and functional responses; 4) characterized effects of [Mg 2ϩ ] o on myocardial adenosine formation; and 5) examined the relative metabolic and functional benefit of elevated [Mg 2ϩ ] o vs. Ca 2ϩ antagonism during ischemia-reperfusion.
METHODS
Isolated perfused rat hearts. Hearts were isolated from mature male Wistar rats as described previously (24) (25) (26) 28) . Rats were anesthetized with 50 mg/kg pentobarbital sodium, a thoracotomy was performed, and the hearts were rapidly excised into ice-cold perfusion fluid. The aorta was immediately cannulated and hearts were perfused in a retrograde manner at a constant hydrostatic pressure of 100 mmHg with modified Krebs bicarbonate buffer containing (in mM) 120 NaCl, 25 NaHCO 3 , 4.7 KCl, 1.25 CaCl 2 , 1.2 MgCl 2 , 15 glucose, and 0.05 EDTA. The perfusate was equilibrated with 95% O 2 -5% CO 2 at 36.5°C, giving a pH of 7.4. The pulmonary artery was cannulated for collection of venous effluent for determination of effluent PO 2 and analysis of venous purine metabolite levels using HPLC (27, 40) . MV O 2 was calculated as the difference between perfusate and venous PO 2 (µl O 2 /ml) multiplied by coronary flow (ml · min Ϫ1 ·g Ϫ1 ) (27, 40) . The left ventricle was vented with a polyethylene apical drain and a fluid-filled latex ventricular balloon inserted via the mitral valve. The balloon was inflated to yield a left ventricular end-diastolic pressure of 2-4 mmHg. The balloon was attached to a P23XL pressure transducer (Viggo-Spectramed, Oxnard, CA) by fluid-filled polyethylene tubing, and ventricular function was continuously monitored on a two-channel MacLab data acquisition unit (ADInstruments, Castle Hill, Australia). The rate-pressure product (heart rate ϫ left ventricular developed pressure) was calculated as an index of ventricular contractile function. After instrumentation hearts were stabilized for a period of 40 min.
31 P nuclear magnetic resonance spectroscopic techniques and determination of phosphate metabolite levels. To assess changes in metabolic state and [Mg 2ϩ ] i , we perfused rat hearts in the bore of a nuclear magnetic resonance (NMR) magnet in a manner similar to that described previously (28) . Consecutive 31 P spectra were acquired at 121.47 MHz using a 90°radiofrequency pulse with an interpulse delay of 1.7 s. Spectral width was 4 kHz, and a total of 4K data points were obtained. Individual spectra consisted of 256 signal-averaged free-induction decays (FID) acquired over consecutive 8-min periods or 160 FID acquired over consecutive 5-min periods in the case of ischemia-reperfusion experiments. FID were multiplied by a 25-Hz line-broadening factor to improve spectral signal to noise. 31 P spectral intensities were determined by integration and corrected for partial relaxation using spin-lattice relaxation times (T 1 ) of 0.94, 2.17, and 1.75 s for ␤-ATP, phosphocreatine (PCr), and P i (28) , respectively. To convert spectral intensities to metabolite concentrations, we determined cytosolic ATP and total creatine (Cr) levels in a group of freeze-clamped control hearts (n ϭ 6). Powdered frozen tissue was extracted with 0.6 M perchloric acid, and neutralized samples were analyzed for ATP, PCr, and Cr as outlined previously (28) . Concentrations were calculated on the basis of a measured intracellular volume of 0.474 ml/g wet wt (see below). The intracellular ATP concentration determined in this way was assigned to the saturation-corrected ␤-ATP intensity from baseline spectra, and all saturation-corrected intensities were normalized against this ATP concentration-to-intensity ratio (28) .
Extracellular and cytosolic volumes were determined for control Langendorff hearts perfused at 100 mmHg pressure with 1.2 mM [Mg 2ϩ ] o and [Ca 2ϩ ] o (n ϭ 7). After 40 min of stabilization hearts were supplied with perfusate containing 0.1 µCi/ml of [ 14 C]mannitol (ICN Biochemicals, Costa Mesa, CA) for a period of 5 min. Perfusate from each heart was sampled for determination of 14 C activity. After the 5-min period of perfusion with [ 14 C]mannitol-enriched perfusate, the hearts were removed and gently blotted, and ϳ300 mg of left ventricular myocardium were frozen in liquid N 2 . Approximately 300 mg were also weighed and then oven-dried at 80°C to a stable weight to measure total water content. The frozen ventricular tissue samples were subsequently pulverized, and powdered tissue was extracted with 0.6 M perchloric acid as described previously (28) . Neutralized extracts were analyzed for [ 14 
The above method of estimating intracellular Na ϩ and K ϩ from total tissue levels minus extracellular contamination has been employed in previous studies (see Ref. 39 and references therein), and we are unaware of evidence supporting significant binding or compartmentation of intracellular Na ϩ and K ϩ . Indeed, microelectrode studies (e.g., Ref. 9) yield estimates of [Na ϩ ] i comparable to those obtained by analysis of total tissue Na ϩ here (see RESULTS) and by others (39) . Additionally, the Nernst potential for K ϩ calculated from the total tissue data (ϳ85 mV) agrees well with direct measures of membrane potential in myocytes (ϳ83 mV, see Ref. 39) , which is predicted assuming a near equilibrium between K ϩ distribution and the resting membrane potential. Measurement of myocardial purine efflux. Venous effluent samples collected from Mg 2ϩ -treated hearts were frozen at Ϫ80°C until analysis for adenosine and inosine by HPLC, as described in detail previously (27, 40) . Adenosine and inosine were identified by retention times and were quantitated by comparison of peak areas with those for known standards run daily with the effluent samples. Data analysis was performed using the Waters Maxima software package (Waters, Milford, MA).
Experimental protocol. . Preliminary studies in which consecutive 4-min spectra were acquired throughout the protocol revealed all metabolic changes were stable after the initial 4-min period (data not shown).
To examine the concentration-dependent inotropic effects of [Mg 2ϩ ] o without interference from chronotropic responses, a series of hearts (n ϭ 7) were stabilized for 30 min as described above before being switched to constant-flow perfusion (at 16.5 Ϯ 1.7 ml · min Ϫ1 ·g Ϫ1 at a mean aortic pressure of 95 Ϯ 7 mmHg) and were electrically paced at 4 Hz. After an additional 10-min stabilization period, baseline functional measurements ( Effects of Ca 2ϩ antagonism were examined in a third group of hearts (n ϭ 8). After acquisition of baseline data, hearts were subjected to stepped elevations in perfusate verapamil from 0 to 0.5 and 2.0 µM. Hearts were stabilized for 4 min at each dose before acquisition of 31 P spectral and functional data.
[ 31 P spectral and functional data.
In the final series of experiments effects of elevated [Mg 2ϩ ] o or Ca 2ϩ channel blockade with verapamil were studied in ischemic-reperfused hearts. After baseline measurements were acquired, hearts were either untreated (n ϭ 7) or subjected to cardioplegic arrest by perfusion with modified buffer containing 25 mM KCl alone (n ϭ 7), 25 mM KCl ϩ 8.0 mM [Mg 2ϩ ] o (n ϭ 8), or 25 mM KCl ϩ 2.0 µM verapamil (n ϭ 8). The NaCl concentration was reduced by 25 mM in all cardioplegic solutions. Cardioplegic perfusion was maintained for 6 min, after which all hearts were subjected to 30 min of total global normothermic ischemia followed by 20 min of reperfusion with normal perfusion fluid (1.2 mM [Mg 2ϩ ] o , 4.7 mM KCl, 0 µM verapamil).
Data analysis. Data reported are means Ϯ SE. The data were analyzed using an ANOVA followed by the NewmanKeuls post hoc test for individual comparisons. In all tests significance was accepted at the 95% confidence level (P Ͻ 0.05). ] o dose dependently reduced peak systolic pressure and heart rate and elevated end-diastolic pressure. The dose dependence for the negative inotropic and chronotropic effects of Mg 2ϩ was comparable (Fig. 1) . The concentration-dependent reduction in inotropic state in the absence of heart rate changes is shown in Fig. 2 . Inotropic sensitivity to [Mg 2ϩ ] o in these hearts is similar to that observed in nonpaced hearts (Fig. 1) . MV O 2 decreased in parallel with contractile function (see Figs. 1 and 4) . A linear correlation was obtained (Fig. 1A) without markedly altering end-diastolic pressure (Fig.  1B) (Table 3 ). Figure 4 depicts the relationship between contractile function (rate-pressure product) and MV O 2 in all groups. A consistent linear correlation was obtained under all conditions studied [MV O 2 ϭ 34.7 ϩ 0.0069 · (rate-pressure product)]. Thus the oxygen cost of isovolumic work appears to be comparable in Mg 2ϩ -, Ca 2ϩ -, and verapamil-treated hearts. Collectively, the data indicate a basal metabolic rate of ϳ35 µl O 2 · min Ϫ1 ·g Ϫ1 (i.e., at zero isovolumic work). It was also found that ⌬G ATP was comparably and linearly correlated with contractile function and MV O 2 in all experimental groups (Fig. 5) . Collectively, these data indicate that the rate of mitochondrial respiration is consistently related to workload and that cytosolic free energy state is consistently related to workload and MV O 2 in hearts treated with either Mg 2ϩ , Ca 2ϩ , or verapamil (Fig. 5) . (Fig. 7) . Similar reductions in purine efflux were also observed in hearts subjected to reduced [Ca 2ϩ ] o (data not shown). (Table 4) . As shown in Fig. 8 , it was calculated that ⌬G [Mg 2ϩ ] o/i increased gradually with ⌬G ATP in the Mg 2ϩ -treated hearts. However, in Ca 2ϩ -and verapamil-treated hearts this relationship did not hold (Fig. 8) (Fig. 8) .
RESULTS

Functional and metabolic effects of elevated [
Ionic changes associated with elevations in [Mg
Functional The extent and time to ischemic contracture varied significantly. End-diastolic pressure increased to 58 Ϯ 12 mmHg at the end of the ischemic period in control hearts and to 55 Ϯ 8, 35 Ϯ 7, and 20 Ϯ 4 mmHg in hearts subjected to high-K ϩ cardioplegic arrest alone or with verapamil or Mg 2ϩ , respectively. Although the K ϩ cardioplegia alone did not significantly alter contracture, verapamil and Mg 2ϩ treatment significantly reduced contracture compared with both control and K ϩ cardioplegia hearts. Contracture in the Mg 2ϩ -treated group was significantly lower than that in the verapamil-treated group (P Ͻ 0.05). Time to contracture was also altered, significantly increasing from 8 Ϯ 1 min in control hearts to 12 Ϯ 1, 15 Ϯ 2, and 20 Ϯ 2 min in hearts subjected to high K ϩ cardioplegic arrest alone or with verapamil or Mg 2ϩ , respectively.
During reperfusion, hearts that were not arrested before global normothermic ischemia recovered ϳ40% of preischemic contractile function (Table 5) . Cardioplegic arrest with K ϩ alone significantly improved contractile recovery, and addition of verapamil or Mg 2ϩ further improved contractile recovery during reperfusion (Table 5) .
Metabolically, cardioplegia reduced the decline in ATP and elevation in P i during the ischemic period (Fig.  9) . Final recovery of ATP and PCr was modestly improved in the high-K ϩ plus Mg 2ϩ treatment group but not significantly improved in any of the other groups (Fig. 9) . P i recovered to preischemic levels in all groups. No differences were observed in responses of pH i or [Mg 2ϩ ] i in the different treatment groups (data not shown). (1, 2, 8, 12, 22, 31, 48, 49, 55) . Responses in rat tissues are more pronounced than those in other species (8, 22, 30 There is controversy with respect to contractile effects of moderate elevations in [Mg 2ϩ ] o in heart. Most studies demonstrate negative inotropic effects of Mg 2ϩ in isolated myocytes (22, 49) , papillary or septal muscle (22, 48) , perfused hearts (8) , and the in situ heart (17). However, Barbour et al. Explanations for these responses included displacement of bound Ca 2ϩ by intracellular Mg 2ϩ , activation of adenylate cyclase, increased cross-bridge number, and intracellular alkalinization (6) . The present data demonstrate that 1. (Table 2) , and a comparable alkalinization occurred with verapamil (Table 2) , suggesting alkalinization is related to Ca 2ϩ channel inhibition, reduced metabolic rate, and/or elevated ⌬G ATP , rather than a specific effect of Mg 2ϩ . Importantly, alkalinization in both experiments was not associated with positive inotropism. The present findings, in conjunction with previous studies (22, 48, 49) , show that moderate elevations in [Mg 2ϩ ] o exert negative inotropic effects in myocardial tissue, and these effects are mediated via extracellular mechanisms, probably involving Ca 2ϩ channel blockade. The positive inotropism observed by Barbour et al. (6) in working hearts may have resulted from the inverse dependence of ventricular force and Ca 2ϩ flux on heart (Table 2 ). This is consistent with our previous studies in in situ rat and rabbit myocardium (28, 40) and with 31 P and 19 F NMR measurements in rat and guinea pig hearts (6, 24-26, 34, 38, 42) . Estimation of [Mg 2ϩ ] i in guinea pig hearts from the Mg 2ϩ -dependent glyceraldehyde-3-phosphate dehydrogenase/phosphoglycerate kinase couple yields values of ϳ0.6 mM (37, 38) , which also agree with the present estimate. Ion-selective microelectrode studies yield similar myocyte [Mg 2ϩ ] i values (9, 10, 22) . Alternatively, estimates of rat heart [Mg 2ϩ ] i from the aconitase equilibrium are variable, ranging from 0.4 to 1.2 mM (33, 39) . This latter technique may be inappropriate in rapidly respiring myocardium owing to displacement of the reaction from equilibrium (37) . (18, 23, 45) . Nevertheless, the existence of myocardial Na ϩ /Mg 2ϩ exchange is controversial, and there is good evidence against such a mechanism (9, 10). Handy et al. (23) recently obtained data favoring a myocardial Na ϩ -Mg 2ϩ antiport. However, their results were also consistent with the operation of other Na ϩ -and/or Ca 2ϩ -dependent pathways (23) .
In examining a potential energy dependence of the transsarcolemmal Mg 2ϩ gradient, we calculated that ⌬G [Mg 2ϩ ] o/i increases gradually as ⌬G ATP rises during Mg 2ϩ infusion (Fig. 8) (Fig. 8) . These data are compatible with electroneutral 2:1 Na ϩ /Mg 2ϩ exchange (15, 16, 18) . Movement of two Na ϩ down an electrochemical gradient, equivalent to a ⌬G of 15 kJ/mol, more than matches the ⌬G for countermovement of a single Mg 2ϩ against its electrochemical gradient (19-23 kJ/mol). A final potential mechanism for Mg 2ϩ extrusion is the action of a Mg 2ϩ -ATPase (15, 16) , similar to those located in bacteria. However, such an enzyme has not been localized in heart tissue, and, as shown here, we observe no consistent relationship between ⌬G [Mg 2ϩ ] o/i and ⌬G ATP , which would be predicted if the Mg 2ϩ gradient were dependent on a sarcolemmal ATPase in a Gibbs-Donnan near-equilibrium system (39 http://ajpheart.physiology.org/ cardioplegic solutions examined reduced contractile function to comparable levels before ischemia, we eliminate a role for preischemic metabolic rate in the differences in recovery (although reduced preischemic workload generally plays a role in cardioplegic protection). Curiously, in examining metabolic effects of cardioplegia with and without Mg 2ϩ as an additive, we observed discrepancies between NMR-detected changes in [P i ] in control vs. cardioplegia-treated hearts (Fig. 9) . For example, [P i ] was ϳ20 mM lower in Mg 2ϩ -treated hearts vs. control hearts despite only a 3 mM difference in [ATP] (which would explain a 9 mM difference in liberated P i , leaving a discrepancy of ϳ10 mM P i ). We have no explanation for reduced [P i ] during ischemia in cardioplegic versus control hearts but recognize that complex relationships exist between total and freely mobile (NMR detected) P i during ischemia as a result of saturable binding of intracellular P i (4 Koss and Grubbs (35) . However, Mg 2ϩ exerts only minor effects on sarcolemmal Na ϩ /Ca 2ϩ exchange (52) . Additional mechanisms include effects of elevated [Mg 2ϩ ] i on ATP synthesis and creatine kinase kinetics (45) , inhibition of mitochondrial Ca 2ϩ accumulation (13, 53) , and modulation of SR Ca 2ϩ uptake and release (12, 41, 51) .
Effects of [Mg 2ϩ ] o on myocardial adenosine formation. Release of adenosine is important in control of cardiovascular function and in protecting the heart from ischemic injury. Adenosine formation is considered to be partially Mg 2ϩ dependent owing to the Mg 2ϩ sensitivity of 5Ј-nucleotidase (24, 38) . It is therefore possible that beneficial effects of Mg 2ϩ could stem in part from adenosine receptor activation subsequent to Mg 2ϩ -dependent elevations in adenosine formation (38) . However, we observed consistent reductions rather than elevations in myocardial adenosine and inosine efflux with increased [Mg 2ϩ ] o (Fig. 6) . Reductions in adenosine efflux parallel changes in MV O 2 , ⌬G ATP , and free cytosolic [AMP] (Fig. 7) . These correlations support the hypothesis that myocardial adenosine formation proceeds via dephosphorylation of intracellular AMP (27, 40) , which increases substantially during reductions in energy state (24, 28, 40) . In this way formation of vasoactive adenosine is coupled to myocardial energy status. The findings are contrary to the observations of Mallet et al. (38) , who recently documented Mg 2ϩ -dependent activation of ecto-5Ј-nucleotidase and adenosine formation despite reduced intracellular [AMP] in guinea pig hearts.
Reasons for the different observations in rat vs. guinea pig are unclear but may involve species differences in 5Ј-nucleotidases. Whereas cytosolic 5Ј-nucleotidases from dog, rabbit, and rat hearts display absolute requirements for Mg 2ϩ , with 50% maximal activation at 1-3 mM (11, 43, 57) , membrane-bound ectoenzyme in rat heart has no absolute requirement for Mg 2ϩ and is only modestly activated (by 70-80%) by elevations in Mg 2ϩ from 0 to 10 mM (43) . On the other hand, whereas the canine membrane-bound enzyme also has no absolute requirement for Mg 2ϩ , it is much more sensitive, being activated by 300-400% with elevations in Mg 2ϩ from 0 to only 6 mM (11). Thus Mg 2ϩ sensitivity of ecto-5Ј-nucleotidase appears to be very modest in rat heart and greater in other species, possibly contributing to the enhanced adenosine release observed in Mg 2ϩ -treated guinea pig hearts (38) but not in Mg 2ϩ -treated rat hearts (present data).
In conclusion, our data indicate that graded elevations in [ [Mg 2ϩ ] o on metabolic and functional variables in hearts subjected to cardioplegic arrest and ischemia. Finally, myocardial adenosine formation in rat heart is not enhanced by [Mg 2ϩ ] o but declines in parallel with Mg 2ϩ -dependent reductions in workload and improvement in energy state. Therefore, the functional and metabolic effects of elevated [Mg 2ϩ ] o in rat myocardium do not involve adenosine receptor activation, and optimal protection of ischemic heart with Mg 2ϩ does not involve enhanced adenosine-mediated cardioprotection.
